EGFR and hepatocellular carcinoma: We also compared the degradation performance of Nanosphere‐Ctx to that of siRNA‐mediated ASGPR knockout hepatoma cells and found that EGFR degradation was more pronounced in HepG2 and Huh7 cells that expressed ASGPR normally (Figure 2H and Figure S2E, Supporting Information).